Midbrain serotonin and striatum dopamine transporter binding in double depression: A one-year follow-up study

Lehto, Soili M.; Tolmunen, Tommi; Kuikka, Jyrki T.; Valkonen‐Korhonen, Minna; Joensuu, Mikko; Saarinen, Pirjo; Vanninen, Ritva; Ahola, Pasi; Tiihonen, Jari; Lehtonen, Johannes

doi:10.1016/j.neulet.2008.06.042

Cited by 39 publications

(24 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With respect to DAT in these non-PD depressed patients, there are results of increased (Laasonen-Balk et al 1999;Brunswick et al 2003;Yang et al 2008), decreased (Meyer et al 2001;Sarchiapone et al 2006), or even no alteration (Argyelan et al 2005;Lehto et al 2008) when depressed patients are compared to healthy control subjects. In the study of Meyer et al (2001), for instance, evaluating depressed patients (n= 9) vs. healthy control subjects (HCS; n=23) using PET (Bressan et al 2007).…”

Section: Discussionmentioning

confidence: 95%

“…In non-PD depressed patients, conflicting results have been obtained showing increased (Laasonen-Balk et al 1999;Brunswick et al 2003;Yang et al 2008), decreased (Meyer et al 2001;Sarchiapone et al 2006), or even no alteration in DAT density (Argyelan et al 2005;Lehto et al 2008) when depressed patients were compared to healthy control subjects.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Higher dopamine transporter density in Parkinson’s disease patients with depression

et al. 2010

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 95%

Section: Introductionmentioning

confidence: 99%

Higher dopamine transporter density in Parkinson’s disease patients with depression

et al. 2010

View full text Add to dashboard Cite

show abstract

“…Two neurotransmitters that have been examined in psychotherapy studies are serotonin and dopamine, both of which have been implicated in types of psychopathology such as depression. For example, changes in serotonin receptor binding have been examined after psychotherapy treatments for depression (Amsterdam et al, 2013; Hirvonen et al, 2011; Karlsson et al, 2010; Lehto et al, 2008a, 2008b). …”

Section: Neuroimaging Methodsmentioning

confidence: 99%

Neuroimaging for psychotherapy research: Current trends

Weingarten

Strauman

2014

Psychotherapy Research

View full text Add to dashboard Cite

Objective This article reviews neuroimaging studies that inform psychotherapy research. An introduction to neuroimaging methods is provided as background for the increasingly sophisticated breadth of methods and findings appearing in psychotherapy research. Method We compiled and assessed a comprehensive list of neuroimaging studies of psychotherapy outcome, along with selected examples of other types of studies that also are relevant to psychotherapy research. We emphasized magnetic resonance imaging (MRI) since it is the dominant neuroimaging modality in psychological research. Results We summarize findings from neuroimaging studies of psychotherapy outcome, including treatment for depression, obsessive-compulsive disorder (OCD), and schizophrenia. Conclusions The increasing use of neuroimaging methods in the study of psychotherapy continues to refine our understanding of both outcome and process. We suggest possible directions for future neuroimaging studies in psychotherapy research.

show abstract

“…Brought to you by | University of Windsor Authenticated Download Date | 10/7/15 9:46 AM Recently some authors reported neurobiological and (in some cases also) clinical changes in different kinds of subjects treated with psychodynamic psychotherapy (Overbeck et al, 2004;Saarinen et al, 2005;Lai et al, 2007;Lehto et al, 2008;Beutel et al, 2010;Kessler et al, 2011;Buchheim et al, 2012;de Greck et al, 2013;Gawrysiak et al, 2013;Kehyayan et al, 2013;Taubner et al, 2013).…”

Section: Backgroundsmentioning

confidence: 99%

The bridge between two worlds: psychoanalysis and fMRI

Marini

Tizio

Dezi

et al. 2016

Reviews in the Neurosciences

View full text Add to dashboard Cite

AbstractIn recent years, a connection between psychoanalysis and neuroscience has been sought. The meeting point between these two branches is represented by neuropsychoanalysis. The goal of the relationship between psychoanalysis and neuroscience is to test psychoanalytic hypotheses in the human brain, using a scientific method. A literature search was conducted on May 2015. PubMed and Scopus databases were used to find studies for the inclusion in the systematic review. Common results of the studies investigated are represented by a reduction, a modulation, or a normalization of the activation patterns found after the psychoanalytic therapy. New findings in the possible and useful relationship between psychoanalysis and neuroscience could change the modalities of relating to patients for psychoanalysts and the way in which neuroscientists plan their research. Researchers should keep in mind that in any scientific research that has to do with people, neuroscience and a scientific method cannot avoid subjective interpretation.

show abstract

Midbrain serotonin and striatum dopamine transporter binding in double depression: A one-year follow-up study

Cited by 39 publications

References 30 publications

Higher dopamine transporter density in Parkinson’s disease patients with depression

Higher dopamine transporter density in Parkinson’s disease patients with depression

Neuroimaging for psychotherapy research: Current trends

The bridge between two worlds: psychoanalysis and fMRI

Contact Info

Product

Resources

About